Frontiers in Endocrinology
Case Report: Efficacy and safety of SGLT2 inhibitors in patients with Alström syndrome: a follow-up report of two siblings from the same family
Case seriesInterventions
2 participants, 11 months
- Ertugliflozin
- Insulin/IGF-1 signalling
- Lipid and ceramide metabolism
- Alström syndrome
- Type 2 diabetes
- Humans
The paper
Henan University of Science and Technology
Frontiers in Endocrinology, 30 Jul 2026
